Imudon is a medicinal product that is released in the form of absorbable tablets and is used to treat various infectious and inflammatory processes in the oral cavity. The country that produces the medicine is France. Let us consider in more detail how the given drug works, in what cases it is prescribed for use, and also what can be replaced by Imudon.
Composition, action and application of Imudon
Imudon belongs to the class of topical immunostimulating drugs of bacterial origin. This medication in its composition contains inactive microorganisms (more precisely, their lysates), which most often cause the development of infectious lesions of the mucous membrane of the mouth and gums (streptococci, staphylococci, candida, enterococci, etc.). Penetrating into the body, they provoke the production in the saliva of protective antibodies, lysozyme, macrophages and lymphocytes. Thus, anti-infectious and anti-inflammatory action appears. An additional effect of the IMUDON tablets is the elimination of an unpleasant odor in the mouth due to the content of the mint flavor.
The drug is used with a therapeutic and preventive purpose for dental diseases and pathologies of ENT organs, accompanied by pain, redness, bad breath, etc., namely:
- stomatitis ;
- periodontitis;
- gingivitis;
- tonsillitis;
- pharyngitis;
- oral dysbiosis;
- postoperative infections of the oral cavity, etc.
Analogues of tablets Imudon
Similar drugs based on bacterial lysates, which in some cases can replace Imudon, are:
- IRS-19 is a domestic preparation manufactured in the form of a nasal spray. It is used to treat and prevent diseases of the upper respiratory tract and bronchi ( sinusitis , tonsillitis, pharyngitis, bronchitis, etc.)
- Broncho-munal is a medicine in the form of gelatin capsules taken orally, intended for the therapy and prevention of infectious diseases of the respiratory tract, including bronchial asthma. Produced in Slovenia.
- Broncho-vaccine is a product also produced in the form of capsules and having similar indications as in the above. Country of origin - Switzerland.
It is worth noting that, despite the fact that drugs based on bacterial lysates exist on the pharmaceutical market for a long time, not all specialists in the medical field consider them to be quite effective.